Clinical therapeutics

Keyphrases

Publications

volume 46, number 7, 2024

Dawn Cooper, Robert W Platt, Florence van Hunsel, Miranda Davies, Alison Yeomans, Samantha Lane, Saad Shakir
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance. Clinical therapeutics 46 (7) (2024)
Juan Joanne Wu, Manfred Hauben, Muhammad Younus
Current Approaches in Postapproval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature. Clinical therapeutics 46 (7) (2024)
Manfred Hauben
A Pharmacovigilance Florilegium. Clinical therapeutics 46 (7) (2024)
Manfred Hauben, Mazin Rafi, Ibrahim Abdelaziz, Oktie Hassanzadeh
Knowledge Graphs in Pharmacovigilance: A Scoping Review. Clinical therapeutics 46 (7) (2024)
Per Sjogren, Bjorn Bragée, Sven Britton
Successful Subcutaneous Immunoglobulin Therapy in a Case Series of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Clinical therapeutics 46 (7) (2024)
Aravind Mittur, Susan A VanMeter, Elmar Orujov, Paul Glidden
Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy Adults. Clinical therapeutics 46 (7) (2024)
Eugenia Rota, Paolo Immovilli, Irene Pappalardo, Roberta Risso, Gabriele Zuccotti, Sergio Agosti, Nicola Morelli, Maria Elena Rovere, Ilaria Costa, Maria Luisa D'Orsi
Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case-Control Study in a Real-World Setting. Clinical therapeutics 46 (7) (2024)
Manfred Hauben, Mazin Rafi
Knowledge Graphs in Pharmacovigilance: A Step-By-Step Guide. Clinical therapeutics 46 (7) (2024)
Xuan Gao, Shuwei Wang, Yi Li, Di Zhou, Xuemei Peng
Clinical Analysis of Different Anesthesia and Analgesia Methods for Patients Undergoing Uniportal Video-assisted Lung Surgery. Clinical therapeutics 46 (7) (2024)
Elena Beyzarov, Yan Chen, Patrick Caubel
A Retrospective Case Series Analysis of Pregnancy and COVID-19 Based on a Global Postmarketing COVID-19 Surveillance Program. Clinical therapeutics 46 (7) (2024)
Paul Beninger
Givinostat Oral Suspension. Clinical therapeutics 46 (7) (2024)
Juan Joanne Wu, Manfred Hauben, Muhammad Younus
Current Approaches in Postapproval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature. Clinical therapeutics 46 (7) (2024)
Hui Yang, Zhuoling An, Yong Zhao, Hezhe Lu
Tacrolimus Related Acute Pancreatitis: An Observational, Retrospective, Pharmacovigilance Study. Clinical therapeutics 46 (7) (2024)
Xuan Gao, Shuwei Wang, Yi Li, Di Zhou, Xuemei Peng
Clinical Analysis of Different Anesthesia and Analgesia Methods for Patients Undergoing Uniportal Video-assisted Lung Surgery. Clinical therapeutics 46 (7) (2024)
Dawn Cooper, Robert W Platt, Florence van Hunsel, Miranda Davies, Alison Yeomans, Samantha Lane, Saad Shakir
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance. Clinical therapeutics 46 (7) (2024)
Manfred Hauben, Mazin Rafi
Knowledge Graphs in Pharmacovigilance: A Step-By-Step Guide. Clinical therapeutics 46 (7) (2024)
Aravind Mittur, Susan A VanMeter, Elmar Orujov, Paul Glidden
Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy Adults. Clinical therapeutics 46 (7) (2024)
Rajesh Gopalarathinam, Reethika Sankar, Sizheng Steven Zhao
Role of Anti-Inflammatory Diet and Fecal Microbiota Transplant in Psoriatic Arthritis. Clinical therapeutics 46 (7) (2024)
Manfred Hauben
A Pharmacovigilance Florilegium. Clinical therapeutics 46 (7) (2024)
Paul Beninger
Givinostat Oral Suspension. Clinical therapeutics 46 (7) (2024)
Eugenia Rota, Paolo Immovilli, Irene Pappalardo, Roberta Risso, Gabriele Zuccotti, Sergio Agosti, Nicola Morelli, Maria Elena Rovere, Ilaria Costa, Maria Luisa D'Orsi
Direct Oral Anticoagulants and Concomitant Anti-seizure Medications: A Retrospective, Case-Control Study in a Real-World Setting. Clinical therapeutics 46 (7) (2024)

volume 46, number 8, 2024

Paul Beninger
Ceftobiprole Medocaril Sodium. Clinical therapeutics 46 (8) (2024)
Linda Nene, Brian Thabile Flepisi, Sarel Jacobus Brand, Charlise Basson, Marissa Balmith
Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence. Clinical therapeutics 46 (8) (2024)
Young-Sim Choi, Jun Gi Hwang, Jae-Won Kim, Hyojin Min, Chang-Hwan Seong, Sung Hee Hong, Na Young Kim, Min Kyu Park
Pharmacodynamics Between a Dual Delayed-Release Formulation of Low-Dose Esomeprazole and Famotidine in Healthy Korean Subjects. Clinical therapeutics 46 (8) (2024)
Adili Tuersun, Guanxin Hou, Gang Cheng
Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials. Clinical therapeutics 46 (8) (2024)
Chaoying Hu, Wanling Sun, Yuanyuan Wu, Junlong Huang, Xiangrong Zhang, Lan Zhang
A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects. Clinical therapeutics 46 (8) (2024)
Ailin Zhang, Yuxuan Sun, Meiling Zuo, Huiyu Wei, Jingtao Chen, Mingfeng Zhao, Wenjie Yang, Liqin Zhu
Physiologically Based Pharmacokinetic Model for Predicting Omadacycline Pharmacokinetics and Pharmacodynamics in Healthy and Hepatic Impairment Populations. Clinical therapeutics 46 (8) (2024)
İlknur Topal, Onur Yılmaz
Effectiveness of Mesotherapy in Post-COVID Pain Syndrome: Retrospective Cohort Study of 96 Patients. Clinical therapeutics 46 (8) (2024)
Byung-Moon Choi, Eunha Kim, Dong Ho Kim, Kyung Mi Kim, Ji-Yeon Bang, Gyu-Jeong Noh, Eun-Kyung Lee
Dosing Strategy of Ramosetron to Prevent Postoperative Nausea and Vomiting and Development of Prediction Models Using Data Obtained From Randomized Controlled Trials: A Comparative Study. Clinical therapeutics 46 (8) (2024)
Linda Nene, Brian Thabile Flepisi, Sarel Jacobus Brand, Charlise Basson, Marissa Balmith
Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence. Clinical therapeutics 46 (8) (2024)
Saroj Jayasinghe
Repurposing Drugs to Treat Novel Infections: A Proposal for a Decision-Making Framework for Clinicians. Clinical therapeutics 46 (8) (2024)
Xiaojuan Ma, Zhuo Chen, Jingzhi An, Cuixin Zhang
Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China. Clinical therapeutics 46 (8) (2024)
Xinyi Zhang, Yuchun Cai, Pei Zhou, Wenchang Nie, Haoning Sun, Yutong Sun, Yuxuan Zhao, Congxiao Han, Chengfu Cao, Jian Liu, Xiaoyan Nie
Pharmacogenomic Polygenic Model of Clopidogrel Predicts Recurrent Ischemic Events in Chinese Patients With Coronary Artery Disease. Clinical therapeutics 46 (8) (2024)
Chaoying Hu, Wanling Sun, Yuanyuan Wu, Junlong Huang, Xiangrong Zhang, Lan Zhang
A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects. Clinical therapeutics 46 (8) (2024)
Bradley J Monk, Ignacio Romero, Whitney Graybill, Cristina Churruca, David M O'Malley, Anja Ør Knudsen, Oi Wah Stephanie Yap, Jean-François Baurain, Peter G Rose, Hannelore Denys, Sharad Ghamande, Carmela Pisano, Michel Fabbro, Elena Ioana Braicu, Paula M Calvert, Amnon Amit, Emily Prendergast, Adekemi Taylor, Leila Kheibarshekan, Zhi-Yi Zhang, Stefan Zajic, Roxanne C Jewell, Divya Gupta, Antonio González-Martín
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer. Clinical therapeutics 46 (8) (2024)
Sizheng Steven Zhao, Dipender Gill
Genetically Proxied IL-6 Receptor Inhibition and Coronary Artery Disease Risk in a Japanese Population. Clinical therapeutics 46 (8) (2024)
Sizheng Steven Zhao, Dipender Gill
Genetically Proxied IL-6 Receptor Inhibition and Coronary Artery Disease Risk in a Japanese Population. Clinical therapeutics 46 (8) (2024)
Paul Beninger
Artificial Intelligence, Drug Development and Frameworks: An Opportunity to Enhance Understanding. Clinical therapeutics 46 (8) (2024)
Xinyi Zhang, Yuchun Cai, Pei Zhou, Wenchang Nie, Haoning Sun, Yutong Sun, Yuxuan Zhao, Congxiao Han, Chengfu Cao, Jian Liu, Xiaoyan Nie
Pharmacogenomic Polygenic Model of Clopidogrel Predicts Recurrent Ischemic Events in Chinese Patients With Coronary Artery Disease. Clinical therapeutics 46 (8) (2024)
Saroj Jayasinghe
Repurposing Drugs to Treat Novel Infections: A Proposal for a Decision-Making Framework for Clinicians. Clinical therapeutics 46 (8) (2024)
İlknur Topal, Onur Yılmaz
Effectiveness of Mesotherapy in Post-COVID Pain Syndrome: Retrospective Cohort Study of 96 Patients. Clinical therapeutics 46 (8) (2024)
Byung-Moon Choi, Eunha Kim, Dong Ho Kim, Kyung Mi Kim, Ji-Yeon Bang, Gyu-Jeong Noh, Eun-Kyung Lee
Dosing Strategy of Ramosetron to Prevent Postoperative Nausea and Vomiting and Development of Prediction Models Using Data Obtained From Randomized Controlled Trials: A Comparative Study. Clinical therapeutics 46 (8) (2024)
Bradley J Monk, Ignacio Romero, Whitney Graybill, Cristina Churruca, David M O'Malley, Anja Ør Knudsen, Oi Wah Stephanie Yap, Jean-François Baurain, Peter G Rose, Hannelore Denys, Sharad Ghamande, Carmela Pisano, Michel Fabbro, Elena Ioana Braicu, Paula M Calvert, Amnon Amit, Emily Prendergast, Adekemi Taylor, Leila Kheibarshekan, Zhi-Yi Zhang, Stefan Zajic, Roxanne C Jewell, Divya Gupta, Antonio González-Martín
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer. Clinical therapeutics 46 (8) (2024)
Xiaojuan Ma, Zhuo Chen, Jingzhi An, Cuixin Zhang
Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China. Clinical therapeutics 46 (8) (2024)
Ailin Zhang, Yuxuan Sun, Meiling Zuo, Huiyu Wei, Jingtao Chen, Mingfeng Zhao, Wenjie Yang, Liqin Zhu
Physiologically Based Pharmacokinetic Model for Predicting Omadacycline Pharmacokinetics and Pharmacodynamics in Healthy and Hepatic Impairment Populations. Clinical therapeutics 46 (8) (2024)
Adili Tuersun, Guanxin Hou, Gang Cheng
Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials. Clinical therapeutics 46 (8) (2024)
Bradley J Monk, Ignacio Romero, Whitney Graybill, Cristina Churruca, David M O'Malley, Anja Ør Knudsen, Oi Wah Stephanie Yap, Jean-François Baurain, Peter G Rose, Hannelore Denys, Sharad Ghamande, Carmela Pisano, Michel Fabbro, Elena Ioana Braicu, Paula M Calvert, Amnon Amit, Emily Prendergast, Adekemi Taylor, Leila Kheibarshekan, Zhi-Yi Zhang, Stefan Zajic, Roxanne C Jewell, Divya Gupta, Antonio González-Martín
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer. Clinical therapeutics 46 (8) (2024)
Paul Beninger
Artificial Intelligence, Drug Development and Frameworks: An Opportunity to Enhance Understanding. Clinical therapeutics 46 (8) (2024)
Young-Sim Choi, Jun Gi Hwang, Jae-Won Kim, Hyojin Min, Chang-Hwan Seong, Sung Hee Hong, Na Young Kim, Min Kyu Park
Pharmacodynamics Between a Dual Delayed-Release Formulation of Low-Dose Esomeprazole and Famotidine in Healthy Korean Subjects. Clinical therapeutics 46 (8) (2024)
Paul Beninger
Ceftobiprole Medocaril Sodium. Clinical therapeutics 46 (8) (2024)